Gender differences in postprandial ketone bodies in normolipidemic subjects and in untreated patients with familial combined hyperlipidemia

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 23, Issue 10, 2003, Pages 1875-1880

  Halkes, C J M ^a   Van Dijk, H ^a   Verseyden, C ^a   De Jaegere, P P Th ^b   Plokker, H W M ^b   Meijssen, S ^a   Erkelens, D W ^a   Castro Cabezas, M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Department of Cardio Thoracic Surgery   (Netherlands)

Author keywords

Abdominal obesity; Apolipoprotein B; Familial combined hyperlipidemia; Insulin resistance

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; COMPLEMENT COMPONENT C3; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYBUTYRIC ACID; KETONE BODY; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACYLATION; ADULT; AREA UNDER THE CURVE; ARTICLE; CALCULATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FAMILIAL HYPERLIPEMIA; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; FEMALE; HUMAN; KETOGENESIS; LIPID DIET; LIVER; LIVER METABOLISM; LOADING TEST; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; POSTPRANDIAL STATE; PRIORITY JOURNAL; SEX DIFFERENCE;

3-HYDROXYBUTYRIC ACID; ADULT; AREA UNDER CURVE; COMPLEMENT C3; DIETARY FATS; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; KETONE BODIES; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; SEX CHARACTERISTICS; TRIGLYCERIDES;

EID: 0141988894     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000092326.00725.ED     Document Type: Article

References (33)

1. Castro Cabezas M, de Bruin TW, de Valk HW, Shoulders CC, Jansen H, Willem ED. Impaired fatty acid metabolism in familial combined hyperlipidemia: a mechanism associating hepatic apolipoprotein B overproduction and insulin resistance. J Clin Invest. 1993;92:160-168.
2. Paolisso G, Tataranni PA, Foley JE, Bogardus C, Howard BV, Ravussin E. A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia. 1995;38:1213-1217.
3. Bergman RN, Van Citters GW, Mittelman SD, Dea MK, Hamilton-Wessler M, Kim SP, Ellmerer M. Central role of the adipocyte in the metabolic syndrome. J Invest Med. 2001;49:119-126.
4. Sniderman AD, Cianflone K, Arner P, Summers LK, Frayn KN. The adipocyte, fatty acid trapping, and atherogenesis. Arterioscler Thromb Vasc Biol. 1998;18:147-151.
5. Meijssen S, Castro Cabezas M, Twickler TB, Jansen H, Erkelens DW. In vivo evidence of defective postprandial and postabsorptive free fatty acid metabolism in familial combined hyperlipidemia. J Lipid Res. 2000;41:1096-1102.
6. Djouadi F, Weinheimer CJ, Saffitz JE, Pitchford C, Bastin J, Gonzalez FJ, Kelly DP. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator. J Clin Invest. 1998;102:1083-1091.
7. Nemoto Y, Toda K, Ono M, Fujikawa-Adachi K, Saibara T, Onishi S, Enzan H, Okada T, Shizuta Y. Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice. J Clin Invest. 2000;105:1819-1825.
8. Halkes CJM, van Dijk H, de Jaegere PPT, Plokker HWM, van der Helm Y, Erkelens DW, Castro Cabezas M. Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: effects of expanded-dose simvastatin. Arterioscler Thromb Vasc Biol. 2001;21:1526-1530.
9. Meijssen S, van Dijk H, Verseyden C, Erkelens DW, Castro Cabezas M. Delayed and exaggerated postprandial complement component 3 response in familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol. 2002;22:811-816.
10. Verseyden C, Meijssen S, Castro Cabezas M. Postprandial changes of apoB-100 and apoB-48 in TG rich lipoproteins in familial combined hyperlipidemia. J Lipid Res. 2002;43:274-280.
11. Krebs M, Stingl H, Nowotny P, Weghuber D, Bischof M, Waldhausl W, Roden M. Prevention of in vitro lipolysis by tetrahydrolipstatin. Clin Chem. 2000;46:950-954.
12. Bodnar JS, Chatterjee A, Castellani LW, Ross DA, Ohmen J, Cavalcoli J, Wu C, Dains KM, Catanese J, Chu M, Sheth SS, Charugundla K, Demant P, West DB, de Jon P, Lusis AJ. Positional cloning of the combined hyperlipidemia gene Hyplip1. Nat Genet. 2001;30:110-116.
13. Jensen MD. Gender differences in regional fatty acid metabolism before and after meal ingestion. J Clin Invest. 1995;96:2297-2303.
14. Riches FM, Watts GF, Naoumova RP, Kelly JM, Croft KD, Thompson GR. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity. Int J Obes Relat Metab Disord. 1998;22:414-423.
15. Wiesenthal SR, Sandhu H, McCall RH, Tchipashvili V, Yoshii H, Polonsky K, Shi ZQ, Lewis GF, Mari A, Giacca A. Free fatty acids impair hepatic insulin extraction in vivo. Diabetes. 1999;48:766-774.
16. D'Eon TM, Sharoff C, Chipkin SR, Grow D, Ruby BC, Braun B. Regulation of exercise carbohydrate metabolism by estrogen and progesterone in women. Am J Physiol Endocrinol Metab. 2002;283: E1046-E1055.
17. Blaak E. Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care. 2001;4:499-502.
18. Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev. 1999;15:412-426.
19. Couillard C, Bergeron N, Prud'homme D, Bergeron J, Tremblay A, Bouchard C, Mauriège P, Després J-P. Gender differences in postprandial lipemia: importance of visceral adipose tissue accumulation. Arterioscler Thromb Vasc Biol 1999;19:2448-2455.
20. Ryu JE, Craven TE, MacArthur RD, Hinson WH, Bond MG, Hagaman AP, Crouse JR. Am J Clin Nutr. 1994;60:586-591.
21. Castro Cabezas M, Halkes CJM, Meijssen S, Van Oostrom AJHMM, Erkelens DW. Diurnal triglyceride profiles: a novel approach to study triglyceride changes. Atherosclerosis. 2001;155:219-228.
22. Halkes CJM, Castro Cabezas M, van Wijk JPH, Erkelens DW. Gender differences in diurnal triglyceridemia in lean and overweight subjects. Int J Obes. 2001;25:1767-1774.
23. Veerkamp MJ, de Graaf J, Bredie SJH, Hendriks JCM, Demacker PNM, Stalenhoef AFH. Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study. Arterioscler Thromb Vasc Biol. 2002;22:274-282.
24. Keulen ETP, Kruijshoop M, Schaper NC, Hoeks APG, de Bruin TWA. Increased intima-media thickness in familial combined hyperlipidemia associated with apolipoprotein B. Arterioscler Thromb Vasc Biol. 2002;22:283-288.
25. Ylitalo K, Syvänne M, Salonen R, Nuotio I, Taskinen M-R, Salonen JT. Carotid artery intima-media thickness in Finnish families with familial combined hyperlipidemia. Atherosclerosis. 2002;162:171-178.
26. Purnell JQ, Kahn SE, Schwartz RS, Brunzell JD. Relationship of insulin sensitivity and apoB levels to intra-abdominal fat in subjects with familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol. 2001;21:567-572.
27. Szkudelska K, Nogowski L, Szkudelski T. Genistein affects lipogenesis and lipolysis in isolated rat adipocytes. J Steroid Biochem Mol Biol. 2000;75:265-271.
28. Cianflone K, Xia Z, Chen LY. Critical review of acylation-stimulating protein physiology in humans and rodents. Biochem Biophys Acta. 2003;1609:127-143.
29. Yudkin JS. Relationship of serum C3 complement with insulin resistance and coronary heart disease-cause, consequence or common antecedent? Eur Heart J. 2000;21:1036-1039.
30. Peterson J, Bihain BE, Bengtsson-Olivecrona G, Deckelbaum RJ, Carpentier YA, Olivecrona T. Fatty acid control of lipoprotein lipase: a link between energy metabolism and lipid transport. Proc Natl Acad Sci U S A. 1990;87:909-913.
31. Karpe F, Olivecrona T, Walldius G, Hamsten A. Lipoprotein lipase in plasma after an oral fat load: relation to free fatty acids. J Lipid Res. 1992;33:975-984.
32. Bjorntorp P. The regulation of adipose tissue distribution in humans. Int J Obes Relat Metab Disord. 1996;20:291-302.
33. Sniderman AD, Maslowska M, Cianflone K. Of mice and men (and women) and the acylation-stimulating protein pathway. Curr Opin Lipidol. 2000;11:291-296.